We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Octapharma’s Nuwiq for Hemophilia
The FDA has approved Octapharma’s Nuwiq, an intravenous therapy that treats bleeding in children and adults with hemophilia A with congenital factor VIII deficiency.